rheumatoid
arthriti
ra
common
type
inflammatori
arthriti
affect
popul
worldwid
regardless
geograph
locat
ethnic
although
etiolog
ra
remain
fulli
elucid
numer
studi
suggest
combin
environment
genet
factor
respons
howev
although
environment
genet
factor
demonstr
import
insuffici
full
express
diseas
primari
inflammatori
site
ra
synovium
prolifer
synovi
fibroblast
one
main
characterist
ra
consid
necessari
initi
longterm
progress
joint
destruct
ra
longterm
joint
destruct
may
lead
limit
function
decreas
work
abil
importantli
decreas
qualiti
life
patient
ra
addit
ra
associ
increas
risk
cardiovascular
diseas
thu
life
expect
patient
ra
may
reduc
year
therefor
inhibit
synovi
hyperplasia
earli
stage
diseas
progress
may
provid
potenti
therapeut
approach
treatment
ra
houttuynia
cordata
thunb
hct
perenni
herbac
plant
grow
wild
moist
shadi
area
numer
asian
countri
includ
india
hct
wide
use
china
japan
asian
countri
medicin
due
antiinflammatori
properti
previou
studi
demonstr
hct
antiinflammatori
effect
wide
rang
diseas
outbreak
hand
foot
mouth
diseas
hfmd
china
hct
use
therapeut
drug
sever
studi
demonstr
hct
inhibit
enteroviru
coxsackieviru
two
main
caus
agent
hfmd
also
demonstr
hct
water
extract
abl
treat
sever
acut
respiratori
syndrom
herp
simplex
viru
infect
sodium
houttuyfon
sh
addit
compound
sodium
bisulfit
houttuynia
stabl
form
houttuynia
exhibit
effect
hct
certain
studi
demonstr
sh
antibacteri
effect
strain
staphylococcu
aureu
previous
use
treatment
cation
bovin
serum
albumininduc
membran
glomerulonephr
balbc
mice
previou
studi
also
demonstr
sh
exert
antiinflammatori
effect
inhibit
tumor
necrosi
pathway
led
hypothesi
sh
may
also
effect
treatment
ra
synovi
tissu
obtain
patient
depart
orthoped
patholog
shanghai
third
peopl
hospit
shanghai
china
sh
purchas
shanghai
qingp
pharmaceut
co
ltd
shanghai
china
batch
number
dhank
solut
nutrient
medium
provid
laboratori
shanghai
third
peopl
hospit
school
medicin
shanghai
jiao
tong
univers
shanghai
china
fetal
bovin
serum
fb
purchas
beij
ruizekang
biotech
co
ltd
beij
china
type
ii
collagenas
trypsin
obtain
shanghai
qifa
experiment
reagent
co
ltd
shanghai
china
mtt
kit
purchas
sigma
st
loui
mo
usa
inform
consent
obtain
patient
fat
fibrou
tissu
remov
synovi
tissu
tissu
wash
three
time
dhank
solut
cut
two
section
mm
size
tissu
place
cultur
bottl
contain
ml
nutrient
solut
fb
ml
type
ii
collagenas
cultur
bottl
incub
h
unattach
cell
transfer
centrifug
tube
centrifug
min
total
ml
trypsin
ad
cell
incub
min
solut
filter
use
nylon
net
follow
centrifug
min
cell
incub
aforement
h
unattach
cell
discard
leav
primari
cell
patient
ra
fig
primari
cell
equal
divid
five
group
follow
control
group
group
cell
treat
sh
group
sh
group
sh
group
sh
group
group
administ
equival
amount
normal
salin
ns
whilst
group
treat
correspond
amount
sh
ns
sh
administ
daili
day
transfer
pipett
follow
final
administr
five
group
synovi
cell
measur
use
mtt
assay
analysi
growth
inhibitori
rate
sh
synovi
prolifer
sequenti
dilut
cell
cultur
medium
cellsml
prepar
total
dilut
analyz
triplic
use
micropl
reader
biorad
hercul
ca
usa
three
control
well
contain
medium
use
absorb
refer
cell
incub
h
total
mtt
reagent
mtt
ad
well
cell
incub
h
purpl
precipit
observ
total
deterg
reagent
ad
well
swirl
gentli
plate
incub
dark
overnight
room
temperatur
absorb
well
nm
measur
use
micropl
reader
final
data
record
result
analyz
absorb
rate
lower
control
consid
indic
reduct
cell
prolifer
contrast
absorb
rate
higher
indic
increas
cell
prolifer
differ
inhibit
rate
group
analyz
use
oneway
analysi
covari
p
consid
indic
statist
signific
differ
shown
fig
prolifer
rate
synovi
cell
markedli
higher
control
group
compar
group
p
shtreat
group
prolifer
rate
synovi
cell
significantli
decreas
compar
group
p
group
p
group
result
indic
sh
decreas
level
synovi
prolifer
cell
patient
ra
fig
show
inhibit
rate
differ
concentr
sh
synovi
prolifer
inhibit
rate
differ
concentr
sh
shown
numer
tabl
correl
coeffici
found
prolifer
synovi
fibroblast
lead
develop
ra
initi
joint
destruct
long
term
previou
studi
demonstr
interleukin
il
import
proinflammatori
cytokin
pathogenesi
ra
inhibit
effect
treatment
patient
ra
notabl
sever
studi
indic
hct
abl
effici
inhibit
addit
nonsteroid
antiinflammatori
drug
nsaid
demonstr
efficaci
treatment
ra
bind
cyclooxygenas
cox
enzym
therefor
inhibit
product
prostaglandin
previou
studi
also
demonstr
hct
supercrit
extract
exert
antiinflammatori
effect
inhibit
pathway
owe
gastrointestin
sideeffect
nsaid
hct
may
better
drug
candid
allevi
symptom
caus
ra
present
studi
demonstr
synovi
prolifer
rate
significantli
decreas
follow
treatment
sh
furthermor
inhibit
rate
sh
found
dose
depend
therefor
result
suggest
sh
abl
inhibit
prolifer
synovi
cell
patient
ra
result
present
studi
provid
potenti
theoret
basi
treatment
ra
furthermor
due
dosedepend
reaction
sh
observ
present
studi
suitabl
dose
sh
may
almost
complet
inhibit
synovi
prolifer
therefor
highli
effect
clinic
treatment
patient
ra
